Literature DB >> 15551009

[Population developments in Germany until 2050].

R Osterkamp1.   

Abstract

While the total population in Germany is expected to diminish until 2050, the proportion of old and very old persons will rise considerably. The annual frequency of sicknesses, clinic days, and fatalities of old persons will likewise strongly increase. This raises difficult problems for the future design of the German public health care system. In any case, reforms will contain elements of rationing which will lead to a less expansion of the field of activity for geriatric physicians and surgeons than the purely demographic development would suggest. This dampening effect of rationing reforms on geriatric medical treatment and surgery, however, might possibly be least when done in an age-specific way and combined with long-term individual provisions through savings and health insurance.

Entities:  

Mesh:

Year:  2005        PMID: 15551009     DOI: 10.1007/s00104-004-0971-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  1 in total

1.  Public health insurance. Pareto-efficient allocative improvements through differentiated copayment rates.

Authors:  R Osterkamp
Journal:  Eur J Health Econ       Date:  2003
  1 in total
  16 in total

1.  Guidelines or state civil codes in the management of femoral neck fracture? An analysis of the reality of care provision in North Rhine-Westphalia.

Authors:  Rüdiger Smektala; Angelika Grams; Ludger Pientka; Ulrich Schulze Raestrup
Journal:  Dtsch Arztebl Int       Date:  2008-04-18       Impact factor: 5.594

2.  [Factors influencing course of hospitalization in patients with hip fractures: Complications, length of stay and hospital mortality].

Authors:  M Muhm; M Walendowski; T Danko; C Weiss; T Ruffing; H Winkler
Journal:  Z Gerontol Geriatr       Date:  2015-06       Impact factor: 1.281

Review 3.  [Importance of anesthesia in multimodal oncologic therapeutical concepts].

Authors:  J Weitz; M A Weigand; P Kienle; D Jäger; M W Büchler; E Martin
Journal:  Anaesthesist       Date:  2006-12       Impact factor: 1.041

4.  [More patients in a shorter inpatient stay with better outcome in treatment of femoral neck fracture: external quality assurance in Westfalia-Lippe on 50,354 patients].

Authors:  R Smektala; U Schulze-Raestrup; C Müller-Mai; H Siebert
Journal:  Unfallchirurg       Date:  2014-11       Impact factor: 1.000

5.  Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis.

Authors:  D B Hoffmann; M Komrakova; S Pflug; M von Oertzen; D Saul; L Weiser; T A Walde; M Wassmann; A F Schilling; W Lehmann; S Sehmisch
Journal:  J Bone Miner Metab       Date:  2018-05-21       Impact factor: 2.626

6.  [Stabilization of unstable intertrochanteric fractures with the proximal femoral nail].

Authors:  S Sehmisch; J Rieckenberg; K Dresing
Journal:  Oper Orthop Traumatol       Date:  2013-02       Impact factor: 1.154

7.  [Early complication rate of fractures close to the hip joint. Dependence on treatment in on-call services and comorbidities].

Authors:  M Muhm; H Hillenbrand; T Danko; C Weiss; T Ruffing; H Winkler
Journal:  Unfallchirurg       Date:  2015-04       Impact factor: 1.000

8.  [Changes in the patient population with proximal femur fractures over the last decade : Incidence, age, comorbidities, and length of stay].

Authors:  Markus Muhm; Matthias Amann; Alexander Hofmann; Thomas Ruffing
Journal:  Unfallchirurg       Date:  2018-08       Impact factor: 1.000

9.  Mortality after proximal femur fracture with a delay of surgery of more than 48 h.

Authors:  M Muhm; D Klein; C Weiss; T Ruffing; H Winkler
Journal:  Eur J Trauma Emerg Surg       Date:  2014-01-25       Impact factor: 3.693

10.  Mortality and quality of life after proximal femur fracture-effect of time until surgery and reasons for delay.

Authors:  M Muhm; G Arend; T Ruffing; H Winkler
Journal:  Eur J Trauma Emerg Surg       Date:  2013-03-08       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.